Novo CEO pressed by Senate to cut prices of obesity, diabetes drugs CEO Lars Fruergaard Jørgensen instructed lawmakers the organization would contemplate new talks with insurers about the listing price ranges of Wegovy and copyright when they pledge to maintain the medicines on their own formularies. The offer need to https://busch-light-peach-calorie18406.blogocial.com/5-simple-techniques-for-healthcare-news-66605525